This Week in Neurosurgery — May 21, 2026

Welcome to This Week in Neurosurgery. This week we're covering 10 notable papers spanning neuro-oncology diagnostics and prognostics, the evolving landscape of neuromodulation and brain-computer interfaces, and a head-to-head comparison of treatments for idiopathic intracranial hypertension. Let's dive in.

First, in neuro-oncology, a series of papers this week address everything from molecular diagnostics and surgical complications to the fundamental biology of common brain tumors. Starting with diagnostics, a study in the Journal of Neuro-oncology explores the use of cerebrospinal fluid for liquid biopsies in glioma patients [1]. Investigators analyzed CSF for circulating tumor DNA, or ctDNA, in 43 patients. They successfully detected mutations in 60 percent of samples, including key diagnostic markers like IDH1 mutations, TERT promoter mutations, and EGFR amplification. The authors note that most of the samples where mutations were not found had suboptimal amounts of DNA for analysis. Critically, the CSF analysis allowed for the molecular reclassification of three patients according to the 2021 WHO classification, highlighting its potential to refine diagnoses without repeat tissue biopsy.

Shifting from diagnostics to surgical complications, another paper in the Journal of Neuro-oncology investigated risk factors for postoperative CSF leak after endoscopic transsphenoidal surgery for craniopharyngioma [4]. In a large multicenter cohort of 416 patients, the overall leak rate was 13.5 percent. While factors like tumor size and prior surgery were not associated with leaks, the use of an intraoperative lumbar drain was. In fact, lumbar drain use was associated with nearly double the odds of a postoperative CSF leak. Conversely, the use of a nasoseptal flap for reconstruction was found to be protective in the earlier years of the study. A survey of participating neurosurgeons revealed a significant perception gap: surgeons identified high-flow leaks and prior surgery as primary risks, and their protocols for lumbar drain use diverged from what the clinical data suggested was beneficial.

Meningioma Biology and Prognosis Two papers this week challenge and refine our understanding of meningiomas. First, a mini-review in Acta Neurochirurgica argues that it's time to move beyond the century-old dogma that all meningiomas arise from arachnoid cap cells [5]. The authors synthesize evidence from single-cell transcriptomics, developmental biology, and animal models to propose that meningiomas likely have a more complex and heterogeneous cellular origin. This could involve different types of progenitor cells depending on the tumor's anatomical location. This conceptual shift may help explain the vast clinical and biological diversity of meningiomas and could inform future classification and treatment strategies.

Building on the theme of improving meningioma care, a study in the Journal of Neuro-oncology questions the supremacy of the Simpson grade for predicting recurrence [10]. In a retrospective analysis of 475 patients, investigators found that while the surgeon's assessment of resection is valuable, postoperative MRI tells a more complete story. In cases of presumed gross total resection, 7 percent of patients had residual tumor on postoperative MRI. The study's key finding from multivariate analysis was that only two factors independently predicted recurrence: high-grade histology and, notably, the relative volume reduction of the tumor measured on MRI. Postoperative tumor volume and relative volume reduction were both better predictors of relapse than the Simpson grade alone. This suggests that routine postoperative MRI provides critical prognostic information for counseling patients and planning follow-up.

Pediatric Cancer Genetics Finally in our oncology roundup, a major study in Nature Medicine provides important data on cancer risk in children with pathogenic germline variants [7]. Researchers analyzed exome sequencing data from over 75,000 pediatric patients who were referred for genetic testing for various reasons, most commonly neurological symptoms. They prospectively followed over 64,000 of these children who did not have a tumor at the time of testing. The results were stark: children carrying pathogenic or likely pathogenic variants in known tumor susceptibility genes had a new cancer incidence of 3.23 per 1,000 person-years. This was more than ten times higher than the incidence in children with variants of uncertain significance or other variants, which was around 0.25 per 1,000 person-years. These findings provide strong evidence supporting proactive genetic counseling and dedicated cancer surveillance for pediatric patients found to have these germline variants, regardless of the initial reason for testing.

Next, we turn to functional neurosurgery and neuromodulation, where new studies explore both invasive and non-invasive techniques to interface with the brain. A study in Science Translational Medicine provides mechanistic evidence for the use of non-invasive transcranial ultrasound stimulation, or TUS, in Parkinson's disease [8]. Researchers used implanted deep brain stimulation electrodes in 17 patients to directly measure neural activity in the subthalamic nucleus, or STN, during TUS. They found that the effects were highly target-specific. When TUS was aimed at the primary motor cortex, it successfully reduced pathological beta oscillation activity in the STN, and this reduction was associated with an improvement in motor signs. In contrast, when TUS targeted the globus pallidus internus, it actually increased beta activity and did not improve motor signs. This work demonstrates that transcranial ultrasound can safely and selectively modulate pathological brain rhythms in deep brain circuits, supporting its potential as a targeted, non-invasive therapy.

Moving to invasive interfaces, a technical note in Operative Neurosurgery details a standardized workflow for the chronic implantation of planar microelectrode arrays, also known as Utah arrays, for a brain-computer interface [3]. The report describes two patients: one with aphasia from a stroke who received four arrays in speech areas, and another with tetraparesis from a spinal cord injury who received four arrays in motor areas related to grasping. The implants have remained functional for as long as 41 months, providing stable, high-quality neuronal recordings with minimal complications. The paper emphasizes a workflow combining preoperative mapping, intraoperative neuronavigation, and structured postoperative surveillance to ensure safety and long-term signal acquisition.

Underpinning these advances, a foundational science paper in Nature provides a glimpse into how the brain may generate complex behaviors [6]. Researchers identified a neural population in the ventral premotor cortex of macaque monkeys that appears to encode 'action symbols.' These are discrete, recombinable units of motor behavior, like individual pen strokes, that are represented in the brain in a way that is independent of low-level motor parameters. The discovery of this neural substrate for symbolic operations provides insight into how the brain can generate novel and flexible behaviors, a key principle for developing more sophisticated brain-computer interfaces.

Finally, a comprehensive review on tinnitus in Nature Reviews Disease Primers touches upon this theme as well [2]. The primer notes that tinnitus affects approximately 14 percent of adults and is a complex condition involving central and peripheral mechanisms. While counseling and cognitive behavioral therapy are first-line treatments, the review highlights that emerging neuromodulation techniques, including bimodal stimulation, are showing benefit for selected patient subgroups, further expanding the clinical reach of this field.

Finally, a single paper in Neurosurgery this week offers a timely comparison of two major weight-loss strategies for idiopathic intracranial hypertension. The Study This multicenter retrospective cohort study compared outcomes for patients with IIH treated with either bariatric surgery or GLP-1 receptor agonists, such as semaglutide or liraglutide [9]. Population Investigators used the TriNetX database to identify adults with IIH and a body mass index of 40 or greater who either underwent bariatric surgery or started on a GLP-1 agonist. They created propensity score-matched cohorts of nearly 1,000 patient pairs for short-term and long-term analyses. Results In the short-term, defined as 3 to 18 months, the bariatric surgery group achieved significantly greater BMI reduction and had lower rates of persistent papilledema and lower use of medications like acetazolamide and topiramate. However, at the long-term follow-up of over 18 months, the outcomes between the two groups were largely comparable in time-to-event analyses. The only significant differences were a higher hazard of nausea and vomiting and continued acetazolamide use in the GLP-1 agonist group. Conclusions The authors conclude that while bariatric surgery remains the most effective intervention for achieving rapid weight loss and symptom improvement, GLP-1 receptor agonists appear to be a durable non-surgical alternative for the long-term management of IIH. This supports an individualized approach to treatment selection based on patient preferences, comorbidities, and surgical candidacy.

If you only have time for one paper this week, make it the study in Neurosurgery comparing bariatric surgery to GLP-1 receptor agonists for idiopathic intracranial hypertension [9]. As GLP-1s become ubiquitous, this paper provides crucial, real-world data showing they are a viable long-term alternative to surgery, fundamentally changing the conversation with patients about weight management strategies for IIH.

Here are the key takeaways from this week in Neurosurgery. First: For meningioma patients, relative volume reduction on a routine postoperative MRI is a powerful predictor of recurrence, potentially more so than the intraoperative Simpson grade. Consider this for risk stratification. Second: In endoscopic craniopharyngioma surgery, the routine use of intraoperative lumbar drains may be associated with a higher risk of postoperative CSF leak, challenging common practice. Third: For patients with IIH and obesity, GLP-1 receptor agonists are emerging as a durable long-term alternative to bariatric surgery, although surgery provides more rapid initial benefit. Fourth: In pediatric patients referred for genetic testing for any reason, the discovery of a pathogenic germline variant in a tumor suppressor gene carries a significant risk for future malignancy, underscoring the need for dedicated surveillance protocols. Fifth: Non-invasive transcranial ultrasound can modulate deep brain circuits in Parkinson's disease in a target-specific manner, providing mechanistic evidence for its therapeutic potential.

That's your roundup for This Week in Neurosurgery. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.